NCT04601038View on ClinicalTrials.gov

Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

PHASE2RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

January 1, 2027

Conditions
Mild Cognitive ImpairmentAlzheimer DiseaseMemory Impairment
Interventions
DRUG

CORT108297

120mg of a selective glucocorticoid receptor antagonist, taken as 2 tablets daily for 2 weeks

DRUG

Placebo

Placebo taken as 2 tablets daily for 2 weeks

Trial Locations (1)

21224

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

Private Philanthropic Funds

OTHER

lead

Johns Hopkins University

OTHER